ARRT MRI study materials
ARRT MRI study resources

"It's Conditional, So We Can Scan It"

ARRT MRI · Put your knowledge to work in context.

All case studies

"It's Conditional, So We Can Scan It"

Mr. K, 68, has a dual-chamber pacemaker implanted 14 months ago for complete heart block and is pacing-dependent at 50 bpm. The referring office says the device is "MRI conditional" and orders a lumbar spine MRI without contrast for radiculopathy. The device card lists a generator model and two lead models, but the cardiology office cannot immediately produce the implant report, and the technologist notices the atrial lead model on the card differs by a suffix from the generator's listed compatible set. Your 3 T scanner has an opening at 3:10 pm; the 1.5 T unit is fully booked. The center closes at 6 pm, and the patient has been NPO since midnight.

1. Is "MRI conditional" sufficient to scan this patient at 3 T this afternoon? What exactly must be verified, and by whom?

Read the worked answer

No. "Conditional" means safe only under the manufacturer's specified conditions, and one unmet condition voids the claim.

Verify, in writing, from the manufacturer's MRI procedure manual for that exact generator and each lead:

  • Device combination: all implanted components must belong to the conditional set. A conditional generator paired with a non-conditional lead is a non-conditional system - this is exactly what the suffix discrepancy on the atrial lead could mean.
  • Field strength: many conditional systems are certified at 1.5 T only; 3 T certification exists only on specific newer platforms. The 3 T opening is therefore not automatically usable.
  • SAR limits: commonly a maximum whole-body SAR (frequently around 2 W/kg) and sometimes head SAR; verify the scanner's predicted values stay below the limit.
  • Gradient slew limits and any restriction on transmit/receive coil type.
  • Implant dwell time (typically at least six weeks) - satisfied here at 14 months.
  • Any position or landmark restriction specific to the model.

Who: the MRI supervising radiologist makes the final call, with confirmation from cardiology or the device manufacturer. Technologists do not adjudicate device eligibility. If the lead model cannot be confirmed, the answer today is no.

2. Assuming the device is confirmed conditional at an appropriate field strength, what programming, monitoring, and personnel are needed for a pacing-dependent patient, and how do you handle the closing-time pressure?

Read the worked answer

Before entering Zone IV:

  • Cardiology reprograms the device to an asynchronous mode (e.g., VOO/DOO) so that RF-induced inhibition cannot leave an asystolic patient; this is done immediately before the scan, not hours earlier.
  • Continuous ECG and pulse oximetry throughout, with a person dedicated to watching the monitor and able to reach the patient.
  • ACLS-trained staff immediately available, MR-conditional resuscitation equipment staged in Zone III, and a documented plan for how the patient leaves the room if something fails.

After the scan: interrogate the device and restore the original mode before the patient leaves the department; do not discharge him still in asynchronous pacing.

On the time pressure: the conditions of use are not negotiable against a 6 pm closing. If reprogramming cannot be completed, the monitoring cannot be staffed, or the verification is not in hand, reschedule - an NPO day is an inconvenience; an unmonitored pacing-dependent patient in a magnet is not. Document that the delay was for safety, and give the patient and referring office a concrete next step (1.5 T slot with cardiology available).

3. The referring physician then asks to add a contrast-enhanced thoracic spine. How does that change your analysis?

Read the worked answer

It changes three things, and any one of them can close the door.

  1. Geometry and artifact. A thoracic spine study puts the isocenter at or near the generator and leads, which increases local RF and gradient exposure and produces substantially more susceptibility artifact over the region of interest. The device may also obscure the very levels being evaluated.
  2. Conditional labeling. Some certifications restrict the region or the landmark position; others cap whole-body SAR in ways a thoracic acquisition can approach. The field-strength condition still governs - a device certified only at 1.5 T cannot be scanned at 3 T because the indication changed.
  3. Workflow. Adding a contrast series extends table time and adds an injection, which means more monitoring time for a pacing-dependent patient and ECG/device compatibility of the injector setup.

The defensible path: re-verify the conditions against the actual protocol and predicted SAR, move to 1.5 T if that is what the certification supports, and if the region cannot be imaged within conditions, offer an alternative study (CT myelography or non-MR imaging) rather than improvising. "We already have him on the table" is not a condition of use.